• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SEOM 临床指南:晚期结直肠癌的治疗。

SEOM clinical guidelines for the treatment of advanced colorectal cancer.

机构信息

Oncology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain.

出版信息

Clin Transl Oncol. 2010 Nov;12(11):729-34. doi: 10.1007/s12094-010-0587-4.

DOI:10.1007/s12094-010-0587-4
PMID:20974564
Abstract

Colorectal cancer is the first cause of cancer diagnosis in Spain. Over half of the patients are diagnosed with or will eventually develop distant metastasis. The current manuscript aims to provide synthetic practical guidelines for the therapeutic approaches in advanced disease. Available systemic therapeutic options, and integration and sequencing of chemotherapy with surgical procedures are discussed. Extent of disease, treatment objective, tumor kras mutation status, as well as patient's functional and comorbid conditions shall be considered to properly design the most adequate therapeutic strategy.

摘要

结直肠癌是西班牙癌症诊断的首要原因。超过一半的患者被诊断出患有或最终将发展为远处转移。本文旨在为晚期疾病的治疗方法提供综合实用的指南。讨论了可用的系统治疗选择,以及化疗与手术的整合和序贯。应考虑疾病的范围、治疗目标、肿瘤 kras 突变状态以及患者的功能和合并症状况,以合理设计最合适的治疗策略。

相似文献

1
SEOM clinical guidelines for the treatment of advanced colorectal cancer.SEOM 临床指南:晚期结直肠癌的治疗。
Clin Transl Oncol. 2010 Nov;12(11):729-34. doi: 10.1007/s12094-010-0587-4.
2
SEOM clinical guidelines for the adjuvant treatment of colorectal cancer.SEOM 结直肠癌辅助治疗临床指南。
Clin Transl Oncol. 2010 Nov;12(11):724-8. doi: 10.1007/s12094-010-0586-5.
3
SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015.2015年SEOM转移性结直肠癌诊断和治疗临床指南
Clin Transl Oncol. 2015 Dec;17(12):972-81. doi: 10.1007/s12094-015-1434-4. Epub 2015 Dec 15.
4
SEOM clinical guidelines for the treatment of advanced colorectal cancer 2013.SEOM 临床指南:2013 年晚期结直肠癌治疗
Clin Transl Oncol. 2013 Dec;15(12):996-1003. doi: 10.1007/s12094-013-1082-5. Epub 2013 Jul 30.
5
Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.中国结直肠癌肝转移诊断和综合治疗指南
J Cancer Res Clin Oncol. 2011 Sep;137(9):1379-96. doi: 10.1007/s00432-011-0999-8. Epub 2011 Jul 28.
6
SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma.SEOM 鼻咽癌治疗临床指南。
Clin Transl Oncol. 2010 Nov;12(11):749-52. doi: 10.1007/s12094-010-0590-9.
7
Colorectal carcinoma: overview of clinical research and management 2011.结直肠癌:2011年临床研究与管理概述
Semin Oncol. 2011 Aug;38(4):481-2. doi: 10.1053/j.seminoncol.2011.05.001.
8
Current standards and new trends in the primary treatment of colorectal cancer.结直肠癌初级治疗的当前标准与新趋势
Eur J Cancer. 2011 Sep;47 Suppl 3:S312-4. doi: 10.1016/S0959-8049(11)70183-6.
9
SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018).SEOM 临床指南:转移性结直肠癌的诊断和治疗(2018)。
Clin Transl Oncol. 2019 Jan;21(1):46-54. doi: 10.1007/s12094-018-02002-w. Epub 2018 Dec 18.
10
SEOM clinical guidelines for the treatment of early breast cancer.SEOM 临床指南:早期乳腺癌的治疗。
Clin Transl Oncol. 2010 Nov;12(11):711-8. doi: 10.1007/s12094-010-0584-7.

引用本文的文献

1
MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer.MiR-107和miR-99a-3p可预测晚期结直肠癌患者的化疗反应。
BMC Cancer. 2014 Sep 7;14:656. doi: 10.1186/1471-2407-14-656.
2
PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome.PDGFRα/β 和 VEGFR2 多态性与结直肠癌:发生率及其对临床结局的影响。
BMC Cancer. 2012 Nov 12;12:514. doi: 10.1186/1471-2407-12-514.
3
Multidisciplinary management in rectal cancer.直肠癌的多学科综合治疗。

本文引用的文献

1
Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.随机、III 期临床试验:帕尼单抗联合氟尿嘧啶、亚叶酸钙和奥沙利铂(FOLFOX4)对比 FOLFOX4 一线治疗未经治疗的转移性结直肠癌患者:PRIME 研究。
J Clin Oncol. 2010 Nov 1;28(31):4697-705. doi: 10.1200/JCO.2009.27.4860. Epub 2010 Oct 4.
2
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.一项比较帕尼单抗联合氟尿嘧啶、亚叶酸钙和伊立替康(FOLFIRI)与单独 FOLFIRI 二线治疗转移性结直肠癌患者的随机 III 期研究。
J Clin Oncol. 2010 Nov 1;28(31):4706-13. doi: 10.1200/JCO.2009.27.6055. Epub 2010 Oct 4.
3
Clin Transl Oncol. 2010 Dec;12(12):805-18. doi: 10.1007/s12094-010-0602-9.
4
The relevance of the Spanish Society for Medical Oncology (SEOM)'s clinical oncology guidelines.西班牙医学肿瘤学会(SEOM)临床肿瘤学指南的相关性。
Clin Transl Oncol. 2010 Nov;12(11):707-8. doi: 10.1007/s12094-010-0582-9.
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer.针对转移性结直肠癌患者,两种不同的含或不含奥沙利铂的一线5-氟尿嘧啶治疗方案。
Ann Oncol. 2009 Feb;20(2):244-50. doi: 10.1093/annonc/mdn638. Epub 2008 Oct 14.
4
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.FOLFOX4围手术期化疗联合手术与单纯手术治疗可切除的结直肠癌肝转移(欧洲癌症研究与治疗组织(EORTC)国际协作组试验40983):一项随机对照试验
Lancet. 2008 Mar 22;371(9617):1007-16. doi: 10.1016/S0140-6736(08)60455-9.
5
Cetuximab for the treatment of colorectal cancer.西妥昔单抗用于治疗结直肠癌。
N Engl J Med. 2007 Nov 15;357(20):2040-8. doi: 10.1056/NEJMoa071834.
6
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.晚期预后不良的结直肠癌患者序贯和联合化疗的不同策略(MRC FOCUS):一项随机对照试验
Lancet. 2007 Jul 14;370(9582):143-152. doi: 10.1016/S0140-6736(07)61087-3.
7
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.卡培他滨、伊立替康和奥沙利铂序贯与联合化疗用于晚期结直肠癌(CAIRO):一项III期随机对照试验
Lancet. 2007 Jul 14;370(9582):135-142. doi: 10.1016/S0140-6736(07)61086-1.
8
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.氟尿嘧啶持续输注、亚叶酸钙、奥沙利铂和伊立替康(FOLFOXIRI)与氟尿嘧啶持续输注、亚叶酸钙和伊立替康(FOLFIRI)用于转移性结直肠癌一线治疗的III期试验:西北肿瘤协作组
J Clin Oncol. 2007 May 1;25(13):1670-6. doi: 10.1200/JCO.2006.09.0928.
9
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.帕尼单抗联合最佳支持治疗与单纯最佳支持治疗用于化疗难治性转移性结直肠癌患者的开放标签III期试验。
J Clin Oncol. 2007 May 1;25(13):1658-64. doi: 10.1200/JCO.2006.08.1620.
10
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.贝伐单抗联合奥沙利铂、氟尿嘧啶和亚叶酸钙(FOLFOX4)用于既往治疗过的转移性结直肠癌:东部肿瘤协作组E3200研究结果
J Clin Oncol. 2007 Apr 20;25(12):1539-44. doi: 10.1200/JCO.2006.09.6305.